LONG READReflections on Covid-19 inbound supply chain issuesCovid-19 has had a significant impact throughout the biopharmaceutical industry, not least on the inbound supply chain, which has been hit by issues such as restricted supplies, the need for new sourcing strategies and how to design and build new facilities.To assess the issues, major supply partners (MSPs) were invited to submit questions to the biomanufacturing members of the Senior...
COVID 19
Viewing related articles
read more
How industry is reacting to the Covid-19 pandemic
Jan 2021 | Cell & Gene Therapy, COVID 19, Covid-19, Deliverables Report, Development Group, Drug Substance, Fill Finish, Information Technology, Long Read, MediPhorum, Publication, Regulatory, Supply Partner, Technology Strategy
LONG READHow industry is reacting to the Covid-19 pandemicKeeping in touch with peers and colleagues has never been more important. Following the postponement of meetings such as the annual Executive BioPhorum meeting, coupled with the heightened need for communication between industry leaders, BioPhorum established the Senior BioPhorum Connect – a group for senior leaders to share ideas, discuss problems and find solutions to counter the...